Vol. 35 Nº 8

Lat. Am. J. Pharm. 35 (8): 1697-1908 (2016)

SUMMARIES OF ARTICLES (to see the full articles enter you username and password)

REGULAR ARTICLES
Design, Synthesis and Biological Evaluation of 2-Thio Benzoxazole Derivatives as Anti-Inflammatory and Analgesic Agents  * YIN D., GAO X., LI Q., ZHAO N. & LONG S.  (1701)
HPLC Method Validation for the Evaluation of Rosuvastatin: Application to Raw Material, Bulk and Pharmaceutical Products  * ALI H., ZAFAR F., SHAH S.N., MALLICK N., NAVEED S., NAQVI G.R., HASNAIN H., MAROOF K. & QURESH S.  (1710)
Synergistic Effect of Melatonin and Atorvastatin in Type 1 Diabetic and Ischemic Injury Cardiomyopathic Sprague Dawley Rats  * ZHANG J., ZHANG Z., YANG B., JING X., ZHONG W. & TANG H.  (1719)
Prescription Errors in Two Mexican Hospitals: Effect of the Use of a Computerized Prescription Order Entry  * NÚÑEZ-SÁNCHEZ A., CORNEJO-BRAVO J.M. & CARRILLO CEDILLO G.  (1725)
Development of mPEG-PLA Based Polymeric Micelles for Controlled Release of Ginkgolide B: In Vitro Evaluation and Pharmacokinetic Study in Rats  * SONG L. & HE S.  (1730)
Competitive Binding of Aspirin and Warfarin to Serum Albumin: a Fluorescence Quenching Study  * ZHANG W., LI L., ZHANG P., SHEN C., LI L., CHEN H. & HUANG X.  (1737)
Quantification of Apixaban in Rat Plasma Using UPLC-MS/MS and its Application to a Pharmacokinetic Study  * JIN X., YANG Y., & HU M.  (1748)
Preparation and Characterization of Chemically Cross-Linked pH Sensitive Poly (EHA-co-IA) Microgels for Controlled Delivery of Diltiazem HCl  * RAZZAQ R., RANJHA N.M., AITAZAZ H., RASHID Z. & RASHID R.  (1754)
Effect of Myricetin on the Pharmacokinetics of Vortioxetine in Rats  * WANG H., WANG H., QIU J., ZHANG Z., & WANG H.  (1763)
Response Surface Methodology Based Optimization of Robust RP-HPLC Method for Estimation of Sorafenib in Pharmaceutical Dosage Formulation  * AHMAD A., ALKHARFY K.M., RAISH M., ALRABIAH H., ALANAZI A.M. & WANI T.A.  (1768)
Pharmacokinetic Study of Docetaxel after Intravenous Administration of Magnesium Isoglycyrrhizinate Injection in Rats by UPLC-MS-MS  * QU B., XING R., GE Q., CHEN X., ZHANG W., ZHAO Y., HU B., PENG D. & CHEN W.  (1776)
In vivo Cytotoxicity of Polysubstituted Pyrazole Derivatives against Liver Cancer Cell Line  * FAHMY H.H., KHALIFA N.M., ISMAIL M.M.F., EL-SAHRAWY H.M., NOSSIER E.S., & ALI M.M.  (1783)
Stability Indicating RP-UHPLC Method Development and Validation of Antipsychotic Drug Risperidone in Self Emulsifying Lipid and Solid Dosage Formulation  * ALQARNI H.M., KAZI M., AHMAD A., RAISH M. & ALANAZI F.K.  (1791)
Pattern of Variable Pharmacokinetic of Clavulanic Acid from Oral Formulation of Co-Amoxiclav Alone and with Antacid in Healthy Subjects  * FATIMA A., NAQVI S.B., YOUNUS I., KHAN Z., KHALIQ S.A. & ALI S.M.  (1799)
In situ Intestinal Absorption Kinetics of Carvedilol Nanosuspensions in Rats  * LIU D., LI J., HE F., WU Q., GE H., YANG X., YU S., WANG X., WANG X. & PAN H.  (1805)
Simultaneous Determination of Five Rat CYP450 Probe Drugs by UPLC-MS/MS Method  * WEI Y., DU H., LIN Y., WU M., YING X., DING M. & HUANG H.  (1810)
The Absolute Bioavailability and Food Effects on Pharmacokinetics of L-3-n-Butylphthalide Tablet in Healthy Chinese Subjects  * WANG M., LOU K., ZHANG Q., PENG Y., HUA W. & HUANG M.  (1816)
Pharmacokinetics and Tolerability of Midazolam and Gender-Related Differences in Volunteers Using LC-MS/MS  * SOUZA FILHO J.H., BEDOR D.C.G., RAMOS V.L.S., SOUSA C.E.M., LEAL L.B. & SANTANA D.P.  (1821)
Assessment of Potential Drug-Drug Interactions in Out-Patients Due to the Trends of Polypharmacy Prescriptions in Pakistan: a Retrospective Cross Sectional Design  * SYED M.A., HANIF S., JAVAID F., RAZAQ S., WAJAHAT I., SAJJAD S. & IJAZ M.  (1829)
Novel Fatty Acid Synthase Inhibitors from the Vines of Polygonum multiflorum Thunb  * LIANG Y., TAN B. & GAO X.  (1838)
Bisphenol F Diglycidyl Ether (BFDGE) Affects the Activity of Anti-Colon Cancer Drugs-Related Drug-Metabolizing Enzymes (DMEs)  * ZHOU Y., LIU Y. & LIU S.  (1844)
A Study on the Combinational Effect of Cholinesterase Inhibitors and NDMA Receptor Antagonist with Herbal Therapy among Alzheimer’sDisease Patients  * ZHANG, Q.  (1850)
Bergapten Attenuates Allergic Inflammation in Mast Cells Through Inhibition of Histamine Release and Pro-Inflammatory Cytokines  * ZHENG D. & CHEN L.  (1855)
Nimesulide Sustained Release Matrix Pellets Prepared by Extrusion/Spheronization  * IBRAHIM M.A., HASSAN M.A., Al ENAZI N.A., MAHMOUD H.A. & EL-BADRY M.  (1861)
Development and Validation of a Microplate Bioassay for Nystatin Using Analytical Quality by Design (QbD) Approach  * JAMIL C.R.P., LOURENÇO F.R., GHISLENI D.D.M. & PINTO T.J.A.  (1871)
Pharmacokinetic Study and UPLC-MS/MS Method Development of Ibrutinib in Mouse  * LIU W., ZHENG X., CHEN K., JIAO Y., & WANG X.  (1877)
Chemical Composition and Antimicrobial Activity of Volatile Oils of Piper amalago L.  * SANTOS V.L.P., LIMA C.O., CAMPOS R., RIBEIRO C.S.R., MARQUES F.A., BUDEL J.M. & MESSIAS-REASON I.J.  (1883)

SHORT COMMUNICATIONS
Synthesis of Pyran-Annulated Heterocycles Derivatives and Evaluation of Their Anti-Osteosarcoma Activity  * XUE L., CAO B., HOU H., YANG J., ZHANG J. & CHEN Y.  (1890)
Determination of Irsogladine Using HPLC-ESI-MS/MS in Human Plasma: Application to Bioequivalence Study  * HOANG N., HUONG N., HONG S. & PARK J.  (1894)
In vivo Characterization of Cefditoren Pivoxil Loaded Floating Microspheres  * CHILUKALA S., BONTHA V.K. & PRAGADA R.R.  (1899)
In Vitro Evidence for Potential Clopidogrel-Propofol Interaction  * ZHANG L., LI H., GAO S., GUAN S., YANG S., YANG Z., SHI C., DAI T. & LI Z.  (1903)

_________________

* English

** Portugûes